drugset / Trial / NCT00413348

Type 2 Diabetes and the Effect of Probiotics

NCT00413348 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

Insulin-resistance in type 2 diabetes is associated with chronic inflammation. Anti-inflammatory actions might increase sensitivity to insulin. Since some probiotics have anti-inflammatory properties, ingestion of the probiotic bacteria Lactobacillus Acidophilus NCFM might increase insulin-sensitivity. The inflammatory response to endotoxin injection and the insulin-sensitivity is examined before and after four weeks ingestion of probiotics.

Timeline

Start
2006-11
Primary completion
—
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus acidophilus NCFM Other / unclassified — —